Robert Esnouf

8.1k total citations · 2 hit papers
76 papers, 6.7k citations indexed

About

Robert Esnouf is a scholar working on Molecular Biology, Infectious Diseases and Virology. According to data from OpenAlex, Robert Esnouf has authored 76 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 25 papers in Infectious Diseases and 21 papers in Virology. Recurrent topics in Robert Esnouf's work include HIV/AIDS drug development and treatment (25 papers), HIV Research and Treatment (21 papers) and Biochemical and Molecular Research (15 papers). Robert Esnouf is often cited by papers focused on HIV/AIDS drug development and treatment (25 papers), HIV Research and Treatment (21 papers) and Biochemical and Molecular Research (15 papers). Robert Esnouf collaborates with scholars based in United Kingdom, Belgium and Germany. Robert Esnouf's co-authors include David I. Stuart, E. Yvonne Jones, D.K. Stammers, Jingshan Ren, Carl Ross, Erik De Clercq, Andrew L. Hopkins, Jan Balzarini, Jan Balzarini and D.O. Somers and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Genetics.

In The Last Decade

Robert Esnouf

76 papers receiving 6.5k citations

Hit Papers

An extensively modified version of MolScript that include... 1997 2026 2006 2016 1997 1999 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Esnouf United Kingdom 34 3.8k 2.0k 1.6k 845 717 76 6.7k
Ben M. Dunn United States 44 3.4k 0.9× 1.7k 0.8× 1.4k 0.9× 410 0.5× 622 0.9× 214 6.1k
Irwin Chaiken United States 42 3.9k 1.0× 987 0.5× 1.3k 0.8× 455 0.5× 821 1.1× 221 6.6k
Jianping Ding China 49 7.8k 2.1× 3.5k 1.8× 3.0k 1.9× 549 0.6× 430 0.6× 187 11.8k
D.K. Stammers United Kingdom 46 3.5k 0.9× 3.3k 1.7× 2.6k 1.7× 711 0.8× 1.1k 1.5× 108 6.8k
Deborah Fass Israel 39 3.8k 1.0× 1.0k 0.5× 1.6k 1.0× 377 0.4× 318 0.4× 84 6.8k
F.F. Vajdos United States 16 4.0k 1.1× 578 0.3× 935 0.6× 675 0.8× 331 0.5× 20 6.1k
Christine Debouck United States 43 3.7k 1.0× 2.0k 1.0× 2.7k 1.7× 172 0.2× 530 0.7× 82 6.9k
Maria Miller United States 28 2.7k 0.7× 1.3k 0.7× 1.2k 0.8× 545 0.6× 586 0.8× 68 4.5k
V.N. Malashkevich United States 34 2.4k 0.6× 673 0.3× 557 0.4× 616 0.7× 273 0.4× 65 4.1k
T.A. Steitz United States 23 4.3k 1.1× 1.5k 0.7× 1.3k 0.8× 626 0.7× 227 0.3× 31 5.7k

Countries citing papers authored by Robert Esnouf

Since Specialization
Citations

This map shows the geographic impact of Robert Esnouf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Esnouf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Esnouf more than expected).

Fields of papers citing papers by Robert Esnouf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Esnouf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Esnouf. The network helps show where Robert Esnouf may publish in the future.

Co-authorship network of co-authors of Robert Esnouf

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Esnouf. A scholar is included among the top collaborators of Robert Esnouf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Esnouf. Robert Esnouf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Bill Yuchen, Jonathan M. Diprose, Susanne L. Griffiths, et al.. (2011). xtalPiMS: A PiMS-based web application for the management and monitoring of crystallization trials. Journal of Structural Biology. 175(2). 230–235. 4 indexed citations
2.
Diprose, Jonathan M., Chris Morris, Susanne L. Griffiths, et al.. (2011). Recording information on protein complexes in an information management system. Journal of Structural Biology. 175(2). 224–229. 4 indexed citations
3.
Paesen, Guido C., Christian Siebold, Mark Dallas, et al.. (2009). An Ion-channel Modulator from the Saliva of the Brown Ear Tick has a Highly Modified Kunitz/BPTI Structure. Journal of Molecular Biology. 389(4). 734–747. 41 indexed citations
4.
Ren, Jingshan, Thomas S. Walter, Karl Harlos, et al.. (2008). Structures of an alanine racemase fromBacillus anthracis(BA0252) in the presence and absence of (R)-1-aminoethylphosphonic acid (L-Ala-P). Acta Crystallographica Section F Structural Biology and Crystallization Communications. 64(5). 327–333. 19 indexed citations
5.
Berry, I., Orly Dym, Robert Esnouf, et al.. (2006). SPINE high-throughput crystallization, crystal imaging and recognition techniques: current state, performance analysis, new technologies and future aspects. Acta Crystallographica Section D Biological Crystallography. 62(10). 1137–1149. 44 indexed citations
6.
Roche, Philippe, Paul T. Christie, Nellie Y. Loh, et al.. (2003). Modeling study of human renal chloride channel (hCLC-5) mutations suggests a structural-functional relationship. Kidney International. 63(4). 1426–1432. 46 indexed citations
7.
Love, Christopher, Karl Harlos, Nasim Mavaddat, et al.. (2003). The ligand-binding face of the semaphorins revealed by the high-resolution crystal structure of SEMA4D. Nature Structural & Molecular Biology. 10(10). 843–848. 130 indexed citations
8.
9.
Balzarini, Jan, Sandra Liekens, André B. P. Kuilenburg, et al.. (2002). Lack of Susceptibility of Bicyclic Nucleoside Analogs, Highly Potent Inhibitors of Varicella-Zoster Virus, to the Catabolic Action of Thymidine Phosphorylase and Dihydropyrimidine Dehydrogenase. Molecular Pharmacology. 61(5). 1140–1145. 31 indexed citations
11.
Laethem, Kristel Van, Myriam Witvrouw, Christophe Pannecouque, et al.. (2001). Mutations in the non-nucleoside binding-pocket interfere with the multi-nucleoside resistance phenotype. AIDS. 15(5). 553–561. 16 indexed citations
12.
Laethem, Kristel Van, Jean‐Claude Schmit, Heidi Pelemans, et al.. (2000). Presence of 2' ,5'-Bis- O -( tert -butyldimethylsilyl)-3-spiro-5"(4"-amino-1",2"-oxathiole-2",2"-dioxide) (TSAO)-Resistant Virus Strains in TSAO-Inexperienced HIV Patients. AIDS Research and Human Retroviruses. 16(9). 825–833. 3 indexed citations
13.
Luyten, Ingrid, Robert Esnouf, Sergey N. Mikhailov, et al.. (2000). Solution Structure of a RNA Decamer Duplex, Containing 9-[2-O-(beta-D-ribofuranosyl)-beta-D-ribofuranosyl]adenine, a Special Residue in Lower Eukaryotic Initiator tRNAs. Helvetica Chimica Acta. 83(6). 1278–1289. 12 indexed citations
14.
Balzarini, Jan, Bart Degrève, Robert Esnouf, et al.. (2000). Kinetic analysis of novel multisubstrate analogue inhibitors of thymidine phosphorylase. FEBS Letters. 483(2-3). 181–185. 33 indexed citations
15.
Ren, Jingshan, Jonathan M. Diprose, Jonathan Warren, et al.. (2000). Phenylethylthiazolylthiourea (PETT) Non-nucleoside Inhibitors of HIV-1 and HIV-2 Reverse Transcriptases. Journal of Biological Chemistry. 275(8). 5633–5639. 102 indexed citations
16.
Balzarini, Jan, Robert Esnouf, Sandra Liekens, et al.. (1998). 7‐Deazaxanthine, a novel prototype inhibitor of thymidine phosphorylase. FEBS Letters. 438(1-2). 91–95. 67 indexed citations
17.
Esnouf, Robert. (1997). An extensively modified version of MolScript that includes greatly enhanced coloring capabilities. Journal of Molecular Graphics and Modelling. 15(2). 132–134. 1628 indexed citations breakdown →
18.
Esnouf, Robert, Jingshan Ren, Carl Ross, et al.. (1995). Mechanism of inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitors. Nature Structural & Molecular Biology. 2(4). 303–308. 369 indexed citations
19.
Ren, Jingshan, Robert Esnouf, Andrew L. Hopkins, et al.. (1995). The structure of HIV-1 reverse transcriptase complexed with 9-chloro-TIBO: lessons for inhibitor design. Structure. 3(9). 915–926. 150 indexed citations
20.
Stammers, D.K., D.O. Somers, Carl Ross, et al.. (1994). Crystals of HIV-1 Reverse Transcriptase Diffracting to 2·2 Å Resolution. Journal of Molecular Biology. 242(4). 586–588. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026